A LinkedIn post from Strive Health describes an in-person meeting of its Clinical Advisory Board, which brought together physician leaders in nephrology to discuss value-based care. The post highlights an opening talk by board member and former Obama administration health policy advisor Kavita Patel, M.D., emphasizing that nephrology may be well positioned to shape emerging value-based models.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The discussions described in the post reportedly focused on how data and technology can better support clinicians, how to structure payer partnerships that prioritize patients, and what a care model built on mutual accountability could look like operationally. For investors, these themes suggest Strive Health is working to align clinical strategy, policy insight, and payer expectations, which could influence its ability to win and execute value-based contracts.
The post also underscores the complexity of the kidney-care landscape, citing shifting policy, advancing technology, and rising performance expectations from payers. If Strive can leverage this advisory board to refine scalable, outcomes-focused care models, it could strengthen its competitive position in the kidney-care and value-based care markets and potentially support longer-term revenue visibility through risk-based arrangements.

